Cargando…
P14-07. Offering new prevention modalities in HIV vaccine trials: experience with male circumcision in the Phambili trial
Autores principales: | de Bruyn, G, Mlisana, K, Metch, B, Churchyard, G, Nchabeleng, M, Bekker, L, Roux, S, Naicker, N, Latka, M, Corey, L, Kublin, J, Gray, G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767687/ http://dx.doi.org/10.1186/1742-4690-6-S3-P195 |
Ejemplares similares
-
P14-02. Social impact events in Phambili, the first phase 2B HIV vaccine trial in South Africa
por: Allen, MA, et al.
Publicado: (2009) -
P15-08. Did unblinding affect HIV risk behaviour and risk perception in the HVTN503/Phambili study?
por: Gray, GE, et al.
Publicado: (2009) -
Pregnancy Incidence and Correlates during the HVTN 503 Phambili HIV Vaccine Trial Conducted among South African Women
por: Latka, Mary H., et al.
Publicado: (2012) -
P13-05. Factors associated with pregnancy during the HVTN 503/Phambili trial, a phase IIB HIV trial of the Merck Ad-5 multi-clade HIV vaccine
por: Latka, M, et al.
Publicado: (2009) -
P15-13. HVTN 503(Phambili) trial discontinuation of enrolment/vaccination: the impact on trial participant attitudes to vaccine trials and scientific research
por: Mark, D, et al.
Publicado: (2009)